Science
3 Things About CRISPR Therapeutics That Smart Investors Know – The Motley Fool
The company’s value isn’t reflected in typical performance metrics.
The gene-editing virtuoso CRISPR Therapeutics (NASDAQ:CRSP) is one of the most-watched stocks in biotech, and it’s no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable…
Continue Reading
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News24 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Noosa News24 hours ago‘They’re not taking the concerns of women seriously’